A: BPC-157 is not FDA-approved for human therapeutic use and is legally classified as a research compound
The announcement removes enforcement risk, so pharmacies that previously declined to compound BPC-157 may now be willing
The documented mechanisms are: VEGF stimulation in dermal fibroblasts that supports the microvascular network feeding the follicle, collagen and glycosaminoglycan synthesis at the follicular basement membrane, anti-inflammatory signaling that calms the chronic micro-inflammation associated with androgenetic alopecia, and direct follicular signaling that extends the anagen growth phase
This isnt a one-size-fits-all approach
Physiologically, patients with asthma frequently experience disruptions in their melatonin levels, namely a delayed acrophase in peak serum concentrations, as well as in the amount of GSH produced in the lung ( In clinical practice, melatonin is often prescribed at a dose of 2mg for the average (70kg) human adult (69)
This approach requires precise dilution and technique, and is typically only performed by experienced practitioners